ReP USP - Resultado da busca

Artigo de periodico
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study (2023)
Weir, Ashley; Kang, Eun-Young; Meagher, Nicola S.; Nelson, Gregg S.; Ghatage, Prafull; Lee, Cheng-Han; Riggan, Marjorie J.; Ryan, Andy; Singh, Naveena; Alsop, Jennifer; Anglesio, Michael S.; Bisinoto, Christiani; Ramus, Susan J. ; Reis, Francisco José Candido dos
Source: British Journal of Cancer. Unidade: FMRP
Subjects: BIOMARCADORES, ADENOCARCINOMA, NEOPLASIAS OVARIANAS, PROGNÓSTICO, RNA MENSAGEIRO, ANÁLISE DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WEIR, Ashley et al. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study. British Journal of Cancer, v. 128, n. 1, p. 137-147, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41416-022-02014-y. Acesso em: 17 nov. 2024.
APA
Weir, A., Kang, E. -Y., Meagher, N. S., Nelson, G. S., Ghatage, P., Lee, C. -H., et al. (2023). Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study. British Journal of Cancer, 128( 1), 137-147. doi:10.1038/s41416-022-02014-y
NLM
Weir A, Kang E-Y, Meagher NS, Nelson GS, Ghatage P, Lee C-H, Riggan MJ, Ryan A, Singh N, Alsop J, Anglesio MS, Bisinoto C, Ramus SJ, Reis FJC dos. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study [Internet]. British Journal of Cancer. 2023 ; 128( 1): 137-147.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/s41416-022-02014-y
Vancouver
Weir A, Kang E-Y, Meagher NS, Nelson GS, Ghatage P, Lee C-H, Riggan MJ, Ryan A, Singh N, Alsop J, Anglesio MS, Bisinoto C, Ramus SJ, Reis FJC dos. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study [Internet]. British Journal of Cancer. 2023 ; 128( 1): 137-147.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/s41416-022-02014-y
Artigo de periodico
Emerging role of PTEN loss in evasion of the immune response to tumours (2020)
Vidotto, Thiago ; Melo, Camila Morais ; Castelli, Erick C. ; Koti, Madhuri ; Reis, Rodolfo Borges dos ; Squire, Jeremy Andrew
Source: British Journal of Cancer. Unidade: FMRP
Subjects: GENÉTICA, NEOPLASIAS, BIOMARCADORES, IMUNOTERAPIA, MUTAÇÃO, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIDOTTO, Thiago et al. Emerging role of PTEN loss in evasion of the immune response to tumours. British Journal of Cancer, v. 122, p. 1732-1743, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41416-020-0834-6. Acesso em: 17 nov. 2024.
APA
Vidotto, T., Melo, C. M., Castelli, E. C., Koti, M., Reis, R. B. dos, & Squire, J. A. (2020). Emerging role of PTEN loss in evasion of the immune response to tumours. British Journal of Cancer, 122, 1732-1743. doi:10.1038/s41416-020-0834-6
NLM
Vidotto T, Melo CM, Castelli EC, Koti M, Reis RB dos, Squire JA. Emerging role of PTEN loss in evasion of the immune response to tumours [Internet]. British Journal of Cancer. 2020 ; 122 1732-1743.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/s41416-020-0834-6
Vancouver
Vidotto T, Melo CM, Castelli EC, Koti M, Reis RB dos, Squire JA. Emerging role of PTEN loss in evasion of the immune response to tumours [Internet]. British Journal of Cancer. 2020 ; 122 1732-1743.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/s41416-020-0834-6
Artigo de periodico
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium (2020)
Martins, Filipe Correia; Couturier, Dominique-Laurent; Paterson, Anna; Karnezis, Anthony N.; Chow, Christine; Nazeran, Tayyebeh M.; Odunsi, Adekunle; Sousa, Christiani B. de; Tiezzi, Daniel Guimarães ; Andrade, Jurandyr Moreira de ; Reis, Francisco José Candido dos
Source: British Journal of Cancer. Unidade: FMRP
Subjects: ADENOCARCINOMA, MORTALIDADE, BIOMARCADORES, NEOPLASIAS OVARIANAS, GENÉTICA, ESTUDOS DE COORTES, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, Filipe Correia et al. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium. British Journal of Cancer, v. 123, p. 793-802, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41416-020-0900-0. Acesso em: 17 nov. 2024.
APA
Martins, F. C., Couturier, D. -L., Paterson, A., Karnezis, A. N., Chow, C., Nazeran, T. M., et al. (2020). Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium. British Journal of Cancer, 123, 793-802. doi:10.1038/s41416-020-0900-0
NLM
Martins FC, Couturier D-L, Paterson A, Karnezis AN, Chow C, Nazeran TM, Odunsi A, Sousa CB de, Tiezzi DG, Andrade JM de, Reis FJC dos. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium [Internet]. British Journal of Cancer. 2020 ; 123 793-802.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/s41416-020-0900-0
Vancouver
Martins FC, Couturier D-L, Paterson A, Karnezis AN, Chow C, Nazeran TM, Odunsi A, Sousa CB de, Tiezzi DG, Andrade JM de, Reis FJC dos. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium [Internet]. British Journal of Cancer. 2020 ; 123 793-802.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/s41416-020-0900-0
Artigo de periodico
Proximity to overhead power lines and childhood leukaemia: an international pooled analysis (2018)
Amoon, Aryana T; Johansen, Christoffer; Kreis, Christian; Malagoli, Carlotta; Marquant, Fabienne; Pedersen, Camilla; RAASCHOU-NIELSEN, OLE; Röösli, Martin; Spycher, Ben D; Sudan, Madhuri; Swanson, John; Crespi, Catherine M; Tittarelli, Andrea; Tuck, Deirdre M; Tynes, Tore; Vergara, Ximena; Vinceti, Marco; Wunsch Filho, Victor ; Kheifets, Leeka; Ahlbom, Anders; Bhatnagar, Megha; Bray, Isabelle; Bunch, Kathryn J; Clavel, Jacqueline; Feychting, Maria; Hémon, Denis
Source: British Journal of Cancer. Unidade: FSP
Subjects: LEUCEMIA, SAÚDE DA CRIANÇA, SAÚDE DO ADOLESCENTE, PREVALÊNCIA, VULNERABILIDADE, CAMPO MAGNÉTICO, LINHAS AÉREAS DE TRANSMISSÃO DE ENERGIA ELÉTRICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMOON, Aryana T et al. Proximity to overhead power lines and childhood leukaemia: an international pooled analysis. British Journal of Cancer, v. 119, n. 3, p. 364-373, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41416-018-0097-7. Acesso em: 17 nov. 2024.
APA
Amoon, A. T., Johansen, C., Kreis, C., Malagoli, C., Marquant, F., Pedersen, C., et al. (2018). Proximity to overhead power lines and childhood leukaemia: an international pooled analysis. British Journal of Cancer, 119( 3), 364-373. doi:10.1038/s41416-018-0097-7
NLM
Amoon AT, Johansen C, Kreis C, Malagoli C, Marquant F, Pedersen C, RAASCHOU-NIELSEN OLE, Röösli M, Spycher BD, Sudan M, Swanson J, Crespi CM, Tittarelli A, Tuck DM, Tynes T, Vergara X, Vinceti M, Wunsch Filho V, Kheifets L, Ahlbom A, Bhatnagar M, Bray I, Bunch KJ, Clavel J, Feychting M, Hémon D. Proximity to overhead power lines and childhood leukaemia: an international pooled analysis [Internet]. British Journal of Cancer. 2018 ;119( 3): 364-373.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/s41416-018-0097-7
Vancouver
Amoon AT, Johansen C, Kreis C, Malagoli C, Marquant F, Pedersen C, RAASCHOU-NIELSEN OLE, Röösli M, Spycher BD, Sudan M, Swanson J, Crespi CM, Tittarelli A, Tuck DM, Tynes T, Vergara X, Vinceti M, Wunsch Filho V, Kheifets L, Ahlbom A, Bhatnagar M, Bray I, Bunch KJ, Clavel J, Feychting M, Hémon D. Proximity to overhead power lines and childhood leukaemia: an international pooled analysis [Internet]. British Journal of Cancer. 2018 ;119( 3): 364-373.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/s41416-018-0097-7
Artigo de periodico
Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy (2013)
Jürgensmeier, J. M.; Schmoll, H-J; Robertson, J. D.; Brooks, L.; Taboada, M.; Morgan, S. R.; Wilson, D.; Hoff, P. M.
Source: British Journal of Cancer. Unidade: FM
Subjects: BIOMARCADORES, NEOPLASIAS (PREVENÇÃO E CONTROLE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JÜRGENSMEIER, J. M. et al. Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy. British Journal of Cancer, v. 108, n. 6, p. 1316-1323, 2013Tradução . . Disponível em: https://doi.org/10.1038/bjc.2013.79. Acesso em: 17 nov. 2024.
APA
Jürgensmeier, J. M., Schmoll, H. -J., Robertson, J. D., Brooks, L., Taboada, M., Morgan, S. R., et al. (2013). Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy. British Journal of Cancer, 108( 6), 1316-1323. doi:10.1038/bjc.2013.79
NLM
Jürgensmeier JM, Schmoll H-J, Robertson JD, Brooks L, Taboada M, Morgan SR, Wilson D, Hoff PM. Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy [Internet]. British Journal of Cancer. 2013 ; 108( 6): 1316-1323.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.2013.79
Vancouver
Jürgensmeier JM, Schmoll H-J, Robertson JD, Brooks L, Taboada M, Morgan SR, Wilson D, Hoff PM. Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy [Internet]. British Journal of Cancer. 2013 ; 108( 6): 1316-1323.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.2013.79
Artigo de periodico
Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy (2013)
Spencer, S. K. M.; Pommier, A. J. C.; Morgan, S. R.; Barry, S. T.; Robertson, J. D.; Hoff, P. M.; Jürgensmeier, J. M.
Source: British Journal of Cancer. Unidade: FM
Subjects: BIOMARCADORES, NEOPLASIAS COLORRETAIS (TERAPIA), ANTINEOPLÁSICOS (APLICAÇÕES TERAPÊUTICAS), PROGNÓSTICO, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPENCER, S. K. M. et al. Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy. British Journal of Cancer, v. 109, n. 11, p. 2765-2773, 2013Tradução . . Disponível em: https://doi.org/10.1038/bjc.2013.649. Acesso em: 17 nov. 2024.
APA
Spencer, S. K. M., Pommier, A. J. C., Morgan, S. R., Barry, S. T., Robertson, J. D., Hoff, P. M., & Jürgensmeier, J. M. (2013). Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy. British Journal of Cancer, 109( 11), 2765-2773. doi:10.1038/bjc.2013.649
NLM
Spencer SKM, Pommier AJC, Morgan SR, Barry ST, Robertson JD, Hoff PM, Jürgensmeier JM. Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy [Internet]. British Journal of Cancer. 2013 ; 109( 11): 2765-2773.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.2013.649
Vancouver
Spencer SKM, Pommier AJC, Morgan SR, Barry ST, Robertson JD, Hoff PM, Jürgensmeier JM. Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy [Internet]. British Journal of Cancer. 2013 ; 109( 11): 2765-2773.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.2013.649
Artigo de periodico
Epidural methadone results in dose-dependent analgesia in cancer pain, further enhanced by epidural dexamethasone (2013)
Lauretti, Gabriela Rocha; Rizzo, Claudia Carvalho; Mattos, A. L.; Rodrigues, S. W.
Source: British Journal of Cancer. Unidade: FMRP
Subjects: NEOPLASIAS, DOR, ANALGESIA, ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAURETTI, Gabriela Rocha et al. Epidural methadone results in dose-dependent analgesia in cancer pain, further enhanced by epidural dexamethasone. British Journal of Cancer, v. 108, n. 2, p. 259-264, 2013Tradução . . Disponível em: https://doi.org/10.1038/bjc.2012.593. Acesso em: 17 nov. 2024.
APA
Lauretti, G. R., Rizzo, C. C., Mattos, A. L., & Rodrigues, S. W. (2013). Epidural methadone results in dose-dependent analgesia in cancer pain, further enhanced by epidural dexamethasone. British Journal of Cancer, 108( 2), 259-264. doi:10.1038/bjc.2012.593
NLM
Lauretti GR, Rizzo CC, Mattos AL, Rodrigues SW. Epidural methadone results in dose-dependent analgesia in cancer pain, further enhanced by epidural dexamethasone [Internet]. British Journal of Cancer. 2013 ; 108( 2): 259-264.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.2012.593
Vancouver
Lauretti GR, Rizzo CC, Mattos AL, Rodrigues SW. Epidural methadone results in dose-dependent analgesia in cancer pain, further enhanced by epidural dexamethasone [Internet]. British Journal of Cancer. 2013 ; 108( 2): 259-264.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.2012.593
Artigo de periodico
Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects (2013)
Ferreira, A. K.; Santana-Lemos, Bárbara Amélia Aparecida; Rego, Eduardo Magalhaes; Filho, O M R; Chierice, Gilberto Orivaldo; Maria, D. A.
Source: British Journal of Cancer. Unidades: FMRP, IQSC
Subjects: LEUCEMIA, NEOPLASIAS COLORRETAIS (TERAPIA), ANTINEOPLÁSICOS (APLICAÇÕES TERAPÊUTICAS), METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, A. K. et al. Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects. British Journal of Cancer, v. 109, n. 11, p. 2819-2828, 2013Tradução . . Disponível em: https://doi.org/10.1038/bjc.2013.510. Acesso em: 17 nov. 2024.
APA
Ferreira, A. K., Santana-Lemos, B. A. A., Rego, E. M., Filho, O. M. R., Chierice, G. O., & Maria, D. A. (2013). Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects. British Journal of Cancer, 109( 11), 2819-2828. doi:10.1038/bjc.2013.510
NLM
Ferreira AK, Santana-Lemos BAA, Rego EM, Filho OMR, Chierice GO, Maria DA. Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects [Internet]. British Journal of Cancer. 2013 ; 109( 11): 2819-2828.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.2013.510
Vancouver
Ferreira AK, Santana-Lemos BAA, Rego EM, Filho OMR, Chierice GO, Maria DA. Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects [Internet]. British Journal of Cancer. 2013 ; 109( 11): 2819-2828.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.2013.510
Artigo de periodico
Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields (2011)
Costa, F. P.; Oliveira, A. C. de; Meirelles, R.; Machado, M. C. C.; Zanesco, T.; Surjan, R.; Chammas, M. C.; Rocha, M de Souza; Morgan, D.; Cantor, A.; Zimmerman, J.; Brezovich, I; Kuster, N.; Barbault, A.; Pasche, B.
Source: British Journal of Cancer. Unidade: FM
Subjects: METÁSTASE NEOPLÁSICA, NEOPLASIAS HEPÁTICAS, TERAPIAS COMPLEMENTARES, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, F. P. et al. Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields. British Journal of Cancer, v. 105, p. 640-648, 2011Tradução . . Disponível em: https://doi.org/10.1038/bjc.2011.292. Acesso em: 17 nov. 2024.
APA
Costa, F. P., Oliveira, A. C. de, Meirelles, R., Machado, M. C. C., Zanesco, T., Surjan, R., et al. (2011). Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields. British Journal of Cancer, 105, 640-648. doi:10.1038/bjc.2011.292
NLM
Costa FP, Oliveira AC de, Meirelles R, Machado MCC, Zanesco T, Surjan R, Chammas MC, Rocha M de S, Morgan D, Cantor A, Zimmerman J, Brezovich I, Kuster N, Barbault A, Pasche B. Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields [Internet]. British Journal of Cancer. 2011 ; 105 640-648.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.2011.292
Vancouver
Costa FP, Oliveira AC de, Meirelles R, Machado MCC, Zanesco T, Surjan R, Chammas MC, Rocha M de S, Morgan D, Cantor A, Zimmerman J, Brezovich I, Kuster N, Barbault A, Pasche B. Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields [Internet]. British Journal of Cancer. 2011 ; 105 640-648.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.2011.292
Artigo de periodico
Pooled analysis of recent studies on magnetic fields and childhood leukaemia (2010)
Kheifets, Leeka; Ahlbom, Anders; Crespi, Catherine M.; Draper, Gerald; Hagihara, Jun; Lowenthal, Raymond M.; Mezei, Gabor; Oksuzyan, Sona; Schüz, Joachim; Swanson, John; Tittarelli, Andrea; Vinceti, Marco; Wünsch Filho, Victor
Source: British Journal of Cancer. Unidade: FSP
Subjects: LEUCEMIA, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KHEIFETS, Leeka et al. Pooled analysis of recent studies on magnetic fields and childhood leukaemia. British Journal of Cancer, v. 103, n. 7, p. 1128-1135, 2010Tradução . . Disponível em: https://doi.org/10.1038/sj.bjc.6605838. Acesso em: 17 nov. 2024.
APA
Kheifets, L., Ahlbom, A., Crespi, C. M., Draper, G., Hagihara, J., Lowenthal, R. M., et al. (2010). Pooled analysis of recent studies on magnetic fields and childhood leukaemia. British Journal of Cancer, 103( 7), 1128-1135. doi:10.1038/sj.bjc.6605838
NLM
Kheifets L, Ahlbom A, Crespi CM, Draper G, Hagihara J, Lowenthal RM, Mezei G, Oksuzyan S, Schüz J, Swanson J, Tittarelli A, Vinceti M, Wünsch Filho V. Pooled analysis of recent studies on magnetic fields and childhood leukaemia [Internet]. British Journal of Cancer. 2010 ; 103( 7): 1128-1135.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/sj.bjc.6605838
Vancouver
Kheifets L, Ahlbom A, Crespi CM, Draper G, Hagihara J, Lowenthal RM, Mezei G, Oksuzyan S, Schüz J, Swanson J, Tittarelli A, Vinceti M, Wünsch Filho V. Pooled analysis of recent studies on magnetic fields and childhood leukaemia [Internet]. British Journal of Cancer. 2010 ; 103( 7): 1128-1135.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/sj.bjc.6605838
Artigo de periodico
Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients (2003)
Lauretti, Gabriela Rocha; Oliveira, G. M.; Pereira, Newton Lindolfo
Source: British Journal of Cancer. Unidades: FMRP, FCFRP
Assunto: FARMACOTÉCNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAURETTI, Gabriela Rocha e OLIVEIRA, G. M. e PEREIRA, Newton Lindolfo. Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients. British Journal of Cancer, v. 89, p. 2027-2030, 2003Tradução . . Disponível em: https://doi.org/10.1038/sj.bjc.6601365. Acesso em: 17 nov. 2024.
APA
Lauretti, G. R., Oliveira, G. M., & Pereira, N. L. (2003). Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients. British Journal of Cancer, 89, 2027-2030. doi:10.1038/sj.bjc.6601365
NLM
Lauretti GR, Oliveira GM, Pereira NL. Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients [Internet]. British Journal of Cancer. 2003 ; 89 2027-2030.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/sj.bjc.6601365
Vancouver
Lauretti GR, Oliveira GM, Pereira NL. Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients [Internet]. British Journal of Cancer. 2003 ; 89 2027-2030.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/sj.bjc.6601365
Artigo de periodico
Prevalence and determinants of human papillomavirus genital infection in men (2002)
Franceschi, S.; Castellsagué, X.; Maso, L. Dal; Smith, J. S.; Plummer, M.; Ngelangel, C.; Chichareon, S.; Eluf Neto, José; Shah, K. V.; Snijders, P. J. F.; Meijer, C. J. L. M.; Bosch, F. X.; Muñoz, N.
Source: British Journal of Cancer. Unidade: FM
Subjects: HÁBITOS, CARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCESCHI, S. et al. Prevalence and determinants of human papillomavirus genital infection in men. British Journal of Cancer, v. 86, n. 5, p. 705-711, 2002Tradução . . Disponível em: https://doi.org/10.1038/sj.bjc.6600194. Acesso em: 17 nov. 2024.
APA
Franceschi, S., Castellsagué, X., Maso, L. D., Smith, J. S., Plummer, M., Ngelangel, C., et al. (2002). Prevalence and determinants of human papillomavirus genital infection in men. British Journal of Cancer, 86( 5), 705-711. doi:10.1038/sj.bjc.6600194
NLM
Franceschi S, Castellsagué X, Maso LD, Smith JS, Plummer M, Ngelangel C, Chichareon S, Eluf Neto J, Shah KV, Snijders PJF, Meijer CJLM, Bosch FX, Muñoz N. Prevalence and determinants of human papillomavirus genital infection in men [Internet]. British Journal of Cancer. 2002 ; 86( 5): 705-711.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/sj.bjc.6600194
Vancouver
Franceschi S, Castellsagué X, Maso LD, Smith JS, Plummer M, Ngelangel C, Chichareon S, Eluf Neto J, Shah KV, Snijders PJF, Meijer CJLM, Bosch FX, Muñoz N. Prevalence and determinants of human papillomavirus genital infection in men [Internet]. British Journal of Cancer. 2002 ; 86( 5): 705-711.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/sj.bjc.6600194
Artigo de periodico
Molecular and immunohistochemical analysis of p53 in phaeochromocytoma (1995)
Dahia, P L M; Aguiar, R C T; Tsanaclis, Ana Maria Crous; Bendit, I; Bydlowski, Sérgio Paulo; Abelin, N M A; Toledo, S. P. A.
Source: British Journal of Cancer. Unidade: FM
Assunto: PATOLOGIA CLÍNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAHIA, P L M et al. Molecular and immunohistochemical analysis of p53 in phaeochromocytoma. British Journal of Cancer, v. no 1995, n. 5 , p. 1211-3, 1995Tradução . . Disponível em: https://doi.org/10.1038/bjc.1995.487. Acesso em: 17 nov. 2024.
APA
Dahia, P. L. M., Aguiar, R. C. T., Tsanaclis, A. M. C., Bendit, I., Bydlowski, S. P., Abelin, N. M. A., & Toledo, S. P. A. (1995). Molecular and immunohistochemical analysis of p53 in phaeochromocytoma. British Journal of Cancer, no 1995( 5 ), 1211-3. doi:10.1038/bjc.1995.487
NLM
Dahia PLM, Aguiar RCT, Tsanaclis AMC, Bendit I, Bydlowski SP, Abelin NMA, Toledo SPA. Molecular and immunohistochemical analysis of p53 in phaeochromocytoma [Internet]. British Journal of Cancer. 1995 ; no 1995( 5 ): 1211-3.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.1995.487
Vancouver
Dahia PLM, Aguiar RCT, Tsanaclis AMC, Bendit I, Bydlowski SP, Abelin NMA, Toledo SPA. Molecular and immunohistochemical analysis of p53 in phaeochromocytoma [Internet]. British Journal of Cancer. 1995 ; no 1995( 5 ): 1211-3.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.1995.487
Artigo de periodico
Abscence of p53 autoantibodies in a significant proportion of breast cancer patients (1995)
Vojtesek, B; Kovanik, J; Dolezalova, H; Nenutil, R; Havlis, P; Brentani, Ricardo Renzo; Lane, D P
Source: British Journal of Cancer. Unidade: FM
Assunto: ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VOJTESEK, B et al. Abscence of p53 autoantibodies in a significant proportion of breast cancer patients. British Journal of Cancer, v. 71, n. ju 1995, p. 1253-6, 1995Tradução . . Disponível em: https://doi.org/10.1038/bjc.1995.242. Acesso em: 17 nov. 2024.
APA
Vojtesek, B., Kovanik, J., Dolezalova, H., Nenutil, R., Havlis, P., Brentani, R. R., & Lane, D. P. (1995). Abscence of p53 autoantibodies in a significant proportion of breast cancer patients. British Journal of Cancer, 71( ju 1995), 1253-6. doi:10.1038/bjc.1995.242
NLM
Vojtesek B, Kovanik J, Dolezalova H, Nenutil R, Havlis P, Brentani RR, Lane DP. Abscence of p53 autoantibodies in a significant proportion of breast cancer patients [Internet]. British Journal of Cancer. 1995 ;71( ju 1995): 1253-6.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.1995.242
Vancouver
Vojtesek B, Kovanik J, Dolezalova H, Nenutil R, Havlis P, Brentani RR, Lane DP. Abscence of p53 autoantibodies in a significant proportion of breast cancer patients [Internet]. British Journal of Cancer. 1995 ;71( ju 1995): 1253-6.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.1995.242
Artigo de periodico
Allelic loss on distal chromosome 17 p is associated with poor prognosis in a group of brazilian breast cancer patients (1994)
Nagai, Maria Aparecida; Pacheco, M M; Brentani, Maria Mitzi; Marques, L A; Brentani, Ricardo Renzo; Ponder, B A; Mulligan, L M
Source: British Journal of Cancer. Unidade: FM
Assunto: ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAGAI, Maria Aparecida et al. Allelic loss on distal chromosome 17 p is associated with poor prognosis in a group of brazilian breast cancer patients. British Journal of Cancer, v. 69, n. 4 , p. 754-8, 1994Tradução . . Disponível em: https://doi.org/10.1038/bjc.1994.142. Acesso em: 17 nov. 2024.
APA
Nagai, M. A., Pacheco, M. M., Brentani, M. M., Marques, L. A., Brentani, R. R., Ponder, B. A., & Mulligan, L. M. (1994). Allelic loss on distal chromosome 17 p is associated with poor prognosis in a group of brazilian breast cancer patients. British Journal of Cancer, 69( 4 ), 754-8. doi:10.1038/bjc.1994.142
NLM
Nagai MA, Pacheco MM, Brentani MM, Marques LA, Brentani RR, Ponder BA, Mulligan LM. Allelic loss on distal chromosome 17 p is associated with poor prognosis in a group of brazilian breast cancer patients [Internet]. British Journal of Cancer. 1994 ;69( 4 ): 754-8.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.1994.142
Vancouver
Nagai MA, Pacheco MM, Brentani MM, Marques LA, Brentani RR, Ponder BA, Mulligan LM. Allelic loss on distal chromosome 17 p is associated with poor prognosis in a group of brazilian breast cancer patients [Internet]. British Journal of Cancer. 1994 ;69( 4 ): 754-8.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.1994.142
Artigo de periodico
Human papillomavirus and invasive cervical cancer in brazil (1994)
Eluf Neto, José; Booth, M; Munoz, N; Bosch, F X; Meijer, C J L M; Walboomers, J M M
Source: British Journal of Cancer. Unidade: FM
Assunto: ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELUF NETO, José et al. Human papillomavirus and invasive cervical cancer in brazil. British Journal of Cancer, v. 69, p. 114-9, 1994Tradução . . Disponível em: https://doi.org/10.1038/bjc.1994.18. Acesso em: 17 nov. 2024.
APA
Eluf Neto, J., Booth, M., Munoz, N., Bosch, F. X., Meijer, C. J. L. M., & Walboomers, J. M. M. (1994). Human papillomavirus and invasive cervical cancer in brazil. British Journal of Cancer, 69, 114-9. doi:10.1038/bjc.1994.18
NLM
Eluf Neto J, Booth M, Munoz N, Bosch FX, Meijer CJLM, Walboomers JMM. Human papillomavirus and invasive cervical cancer in brazil [Internet]. British Journal of Cancer. 1994 ;69 114-9.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.1994.18
Vancouver
Eluf Neto J, Booth M, Munoz N, Bosch FX, Meijer CJLM, Walboomers JMM. Human papillomavirus and invasive cervical cancer in brazil [Internet]. British Journal of Cancer. 1994 ;69 114-9.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/bjc.1994.18
Artigo de periodico
Somatic changes in b- lymphoproliferative disorders (b-lpd) detected by dna- fingerprinting (1988)
De Jong, David; Voetdijk, B M H; Kluin-Nelemans, J C; Van Ommen, G J B
Source: British Journal of Cancer. Unidade: FMRP
Assunto: GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE JONG, David et al. Somatic changes in b- lymphoproliferative disorders (b-lpd) detected by dna- fingerprinting. British Journal of Cancer, v. 58, n. 6 , p. 773-5, 1988Tradução . . Acesso em: 17 nov. 2024.
APA
De Jong, D., Voetdijk, B. M. H., Kluin-Nelemans, J. C., & Van Ommen, G. J. B. (1988). Somatic changes in b- lymphoproliferative disorders (b-lpd) detected by dna- fingerprinting. British Journal of Cancer, 58( 6 ), 773-5.
NLM
De Jong D, Voetdijk BMH, Kluin-Nelemans JC, Van Ommen GJB. Somatic changes in b- lymphoproliferative disorders (b-lpd) detected by dna- fingerprinting. British Journal of Cancer. 1988 ;58( 6 ): 773-5.[citado 2024 nov. 17 ]
Vancouver
De Jong D, Voetdijk BMH, Kluin-Nelemans JC, Van Ommen GJB. Somatic changes in b- lymphoproliferative disorders (b-lpd) detected by dna- fingerprinting. British Journal of Cancer. 1988 ;58( 6 ): 773-5.[citado 2024 nov. 17 ]

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration